Stéphane Bancel, Moderna CEO (Charles Krupa/AP Images)

Covid-19 roundup: Bi­va­lent vac­cines to be au­tho­rized by La­bor Day — re­port; Mod­er­na knocks on FDA's door for boost­ers

The Ad­vi­so­ry Com­mit­tee on Im­mu­niza­tion Prac­tices, which com­pris­es pub­lic health ex­perts who de­vel­op rec­om­men­da­tions on the use of vac­cines, is all set to hold two-day meet­ings next week to dis­cuss Covid-19 vac­cine boost­er dos­es, ac­cord­ing to a CBS News re­port. If all goes ac­cord­ing to plan, the bi­va­lent shots should be au­tho­rized and avail­able to the pub­lic by La­bor Day.

If the pan­el gives the thumbs-up, both Mod­er­na and Pfiz­er/BioN­Tech’s shots will be avail­able in the US for the gov­ern­ment’s fall vac­ci­na­tion cam­paign.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.